Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line: Structure, Activity, and Application
Introduction
The Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and function of the CD269/TNFRSF17/BCMA receptor in various biological processes. This stable cell line is derived from the human embryonic kidney (HEK) 293T cell line, which is commonly used in research for its high transfection efficiency and ability to produce large quantities of recombinant proteins.
Structure of CD269/TNFRSF17/BCMA Receptor
The CD269/TNFRSF17/BCMA receptor, also known as B cell maturation antigen, is a type III transmembrane protein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. It is primarily expressed on B cells and plays a critical role in regulating B cell survival and differentiation. The receptor consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain contains two cysteine-rich domains, which are important for ligand binding, and a conserved TNFR-associated factor (TRAF) binding site in the intracellular domain, which is essential for downstream signaling.
Activity of CD269/TNFRSF17/BCMA Receptor
The CD269/TNFRSF17/BCMA receptor is activated by two known ligands, B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL). Binding of these ligands to the receptor leads to the recruitment of TRAF proteins, which initiate downstream signaling cascades. This results in the activation of various transcription factors, such as NF-κB and MAPK, which regulate the expression of genes involved in B cell survival, proliferation, and differentiation. Dysregulation of CD269/TNFRSF17/BCMA signaling has been linked to various autoimmune diseases and B cell malignancies, making it an important therapeutic target.
Application of Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line
The Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line is a valuable tool for studying the structure and function of the CD269/TNFRSF17/BCMA receptor. It can be used to investigate ligand-receptor interactions, downstream signaling pathways, and the effects of genetic mutations on receptor activity. Additionally, this stable cell line can be used to screen potential drugs or therapeutic agents targeting the CD269/TNFRSF17/BCMA pathway. The ability to express recombinant CD269/TNFRSF17/BCMA in a stable cell line allows for the production of large quantities of the receptor, making it a cost-effective and efficient tool for research and drug development.
Flow Cytometry Analysis of CD269/TNFRSF17/BCMA Expression
Flow cytometry is a powerful technique for analyzing the expression of cell surface markers, such as CD269/TNFRSF17/BCMA. The Human CD269/TNFRSF17/BCMA HEK293T Stable Cell Line can be used for flow cytometry analysis to determine the level of CD269/TNFRSF17/BCMA expression on the cell surface. This can be useful for studying the regulation of receptor expression and for identifying potential ligands or inhibitors that can modulate CD269/TNFRSF17/BCMA activity.
There are no reviews yet.